The DOI matches its Crossref record, with a small difference in title or year; 119 of the 119 references it cites were found in a registry or an index.
Metabolic syndrome and hepatocellular carcinoma: Two growing epidemics with a potential link
Open accessAbstract
Hepatocellular carcinoma (HCC) is the most rapidly increasing cause of cancer death in the United States. Although many risk factors for HCC are well defined, including hepatitis B virus (HBV), hepatitis C virus (HCV), and alcohol, most series have indicated that 5% to 30% of patients with HCC lack a readily identifiable risk factor for their cancer. The majority of “cryptogenic” HCC in the United States is attributed to nonalcoholic fatty liver disease (NAFLD), a hepatic manifestation of the metabolic syndrome. The metabolic syndrome is a constellation of problems that includes insulin resistance, obesity, hypertension, and hyperlipidemia. Increasingly, components of the metabolic syndrome are being linked to various forms of cancer with respect to both increased risk of disease and worsened outcome. In this review, the authors focused on the relation between metabolic syndrome and HCC. They investigated the increased risks of HCC among individuals with features of metabolic syndrome, potentially worsened cancer outcomes in these patients, possible pathogenic mechanisms to explain these relations, and treatment options for those with NAFLD and its progressive counterpart, nonalcoholic steatohepatitis. It is predicted that metabolic syndrome will lead to large increases in the incidence of HCC over the next decades. A better understanding of the relation between these 2 diseases ultimately should lead to improved screening and treatment options for patients with HCC. Cancer 2009. © 2009 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“non-alcoholic fatty liver disease (NAFLD) is predicted to become the leading cause of HCC in the 21st century as a secondary consequence of the obesity pandemic (Siegel and Zhu, 2009).”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Siegel and Zhu, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,974
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
Research works printed but not linked: 1
- 10.1111/j.1572-0241.2005.41583.x · DOI
Cited by
Sorted by citations
Items 301–398 of 398
Sicklick, J. K., D'Angelica, M. I., & Fong, Y. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1560-6.00054-8 · Cited by 5
Cui, S., Zhang, M., Bai, S., Bi, Y., Cong, S., Jin, S., Li, S., He, H., & Zhang, J. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/1847700 · Cited by 5
Tumours and Tumour-Like Lesions
Ferrell, L. D., Kakar, S., Terracciano, L., & Wee, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00013-2 · Cited by 5
Wu, R., Chen, X., Chen, H., Li, M., & Liang, Y. (2024) · Oncology Letters · doi:10.3892/ol.2024.14737 · Cited by 4
HCC in MASLD and ALD: Biochemical Pathways, Epidemiology, Diagnosis, and Treatment
Patel, S. A., Kasem, F., Flaherty, D. T., & Barve, A. J. (2025) · BioChem · doi:10.3390/biochem5030019 · Cited by 4
Clinical Case Panel: Treatment Alternatives for Inoperable Hepatocellular Carcinoma
Toesca, D. A. S., Barry, A. S., Sapisochín, G., Beecroft, R., Dawson, L. A., Owen, D., Mouli, S. K., Lewandowski, R. J., Salem, R., & Chang, D. T. (2018) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2018.08.001 · Cited by 4
Functional Foods for Treatment and Prevention of Obesity and Its Associated Disorders
Tingirikari, J. M. R. (2018) · Advances in human services and public health (AHSPH) book series · doi:10.4018/978-1-5225-3267-5.ch004 · Cited by 4
Alcohol and Cancer Epidemiology
Gentry, R. T. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0040-0_3 · Cited by 4
Teixeira, A. C. (2012) · World Journal of Oncology · doi:10.4021/wjon549w · Cited by 4
Ishizuka, M., Kubota, K., Kita, J., Shimoda, M., Kato, M., & Sawada, T. (2013) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2012.08.011 · Cited by 4
Épidémiologie du carcinome hépatocellulaire : simple augmentation d’incidence ou futur drame ?
Raoul, J., Raimbourg, J., Hiret, S., Adhoute, X., & Senellart, H. (2018) · Bulletin du Cancer · doi:10.1016/j.bulcan.2018.02.003 · Cited by 4
Hepatocellular Carcinoma: A Review
Gupta, T. (2020) · Journal of Renal and Hepatic Disorders · doi:10.15586/jrenhep.v4i2.84 · Cited by 5
Siegel, A. B. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5367 · Cited by 4
Self-citationSaid, A. H., Shetty, K., Li, Y., Blechacz, B. R. A., Hawk, E. T., & Mishra, L. (2012) · doi:10.1002/9781118423318.ch7 · Cited by 4
Brunson, C., Struycken, L., Schaub, D., Ref, J., Goldberg, D., Hannallah, J. R., Woodhead, G. J., & Young, S. J. (2024) · Abdominal Radiology · doi:10.1007/s00261-024-04295-8 · Cited by 3
Wei, T., Zhang, X., Bagante, F., Ratti, F., Marques, H. P., Soubrane, O., Lam, V. W. T., Poultsides, G. A., Popescu, I., Alexandrescu, S. T., et al. (2020) · HPB · doi:10.1016/j.hpb.2020.01.003 · Cited by 3
Obesity and cancers of the liver, gallbladder, and pancreas
Sarna, M. J., & Giorgi, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90965-5.00002-7 · Cited by 3
Kroh, A., Schmitz, S. M., Köhne, S., Andruszkow, J., Nolting, J., Preisinger, C., Große, K., Eickhoff, R., Heise, D., Cramer, T., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38678 · Cited by 5
Benign Hepatocellular Tumors: A Multidisciplinary Approach
Bioulac‐Sage, P., Grazioli, L., Terkivatan, T., & Chang, C. (2013) · International Journal of Hepatology · doi:10.1155/2013/153693 · Cited by 3
Kawamura, Y., Ikeda, K., Arase, Y., Fujiyama, S., Hosaka, T., Kobayashi, M., Saitoh, S., Sezaki, H., Akuta, N., Suzuki, F., et al. (2017) · Internal Medicine · doi:10.2169/internalmedicine.56.7830 · Cited by 3
[The Development of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease].
Kwon, O., Kim, J., & Kim, J. H. (2017) · The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · doi:10.4166/kjg.2017.69.6.348 · Cited by 3
Mechanisms Linking Obesity to Cancer Risk
Imayama, I., Mason, C. E., & Duggan, C. R. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7551-5_6 · Cited by 3
Article Commentary: Insulin Resistance, Type 2 Diabetes and Chronic Liver Disease. A Deadly Trio
Lonardo, A., & Loria, P. (2009) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.4137/cmed.s3518 · Cited by 3
Tsai, K., Liu, P., Lin, Y.-C., Huang, C.-M., Wang, H.-S., & Lin, G. (2025) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303323078241022050619 · Cited by 2
Decker, J. A., Scheurig‐Muenkler, C., Luitjens, J. H., & Kroencke, T. J. (2023) · Cancers · doi:10.3390/cancers15102792 · Cited by 2
Huang, J., Tao, Y., Yao, J., Song, X., Li, Y., & Yuan, Y. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1542328 · Cited by 2
Yeom, S., Lee, D. H., & Song, J. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70446 · Cited by 3
Etiology and Pathogenesis of Hepatocellular Carcinoma: Inflammatory and Toxic Causes
Zimmermann, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-26956-6_164 · Cited by 2
Mitogen-Activated Protein Kinase Phosphatases in Metabolism
Lawan, A., & Bennett, A. M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7855-3_12 · Cited by 2
Arrese, M. A., Arab, J. P., Arancibia, J. P., Cândia, R., Riquelme, A. J., & Francisco Barrera, M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385083-6.00023-1 · Cited by 2
Cruveilhier-Baumgarten syndrome--a caveat for surgeons.
Dlangamandla, S., Lucas, S., Andronikou, S., Rubin, G., Boshoff, P. E., Malek, L., & Eshragi, H. (2011) · PubMed · Cited by 2
The effect of inflammation on presence of cancer
Shiva, A., & Arab, S. (2015) · Clinical Excellence · Cited by 2
HEPATIC CANCER AND ITS RISK FACTORS IN NOVOSIBIRSK
Reshetnikov, O. V., Опенко, Т. Г., Kurilovich, S. A., Khryanin, А. А., & Malyutina, S. K. (2016) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2016-15-3-19-27 · Cited by 2
HCC in Elderly Patients. Curative Intraoperative Strategies and Management in Recurrences
Brozzetti, S., Bini, S., Chiarella, L. L., Fazzi, K., Martino, M. D., & Bezzi, M. (2018) · Liver Cancer · doi:10.5772/intechopen.79748 · Cited by 4
Evaluation and impact of different biomarkers for early detection of hepatocellular carcinoma
Best, J., Sydor, S., Bechmann, L. P., & Canbay, A. E. (2020) · Hepatoma Research · doi:10.20517/2394-5079.2020.56 · Cited by 2
Wirth, A. G., Hauner, H., Roden, M., Parhofer, K. G., May, M., Engeli, S., Jordan, J., Schulz, R., Schneider, K. T. M., Grote, V. A., et al. (2013) · Springer eBooks · doi:10.1007/978-3-642-22855-1_6 · Cited by 2
Monosodium glutamate in foods and its biological importance
Henry-Unaeze, H. N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-816011-4.00022-7 · Cited by 2
Hu, Y., Hao, C., Dong, C., Tao, P., Wang, J., & Lu, Q. (2025) · Discover Oncology · doi:10.1007/s12672-025-03123-9 · Cited by 1
REGULATION OF HEPATIC GENE EXPRESSION DURING LIVER DEVELOPMENT AND DISEASE
Ren, H. (2012) · UKnowledge (University of Kentucky) · Cited by 1
Snake Venom and Therapeutic Potential
Nassar, M. I. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101421 · Cited by 1
Zebrafish: A Model Organism to Understand Tumor Angiogenesis Mechanism
Hariprabu, K. N. G., Yuvashree, R., & Vimalraj, S. (2022) · Springer eBooks · doi:10.1007/978-981-16-5217-2_2 · Cited by 1
S., L. C., & Guillermo Silva, P. (2015) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2015.09.006 · Cited by 1
Etiology and Pathogenesis of Hepatocellular Carcinoma: Inflammatory and Toxic Causes
Zimmermann, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-26587-2_164-1 · Cited by 1
Rosmorduc, O., & Fartoux, L. (2014) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31173-2 · Cited by 2
Obesity and Metabolic Syndrome in Children: What’s New?
Nunes, M. (2017) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2017.04.00090 · Cited by 1
Schattenberg, J. M. (2009) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.4137/cmed.s3497 · Cited by 1
Non‐Alcoholic Fatty Liver Disease, Hepatocellular Cancer, and Other Cancers
Graham, J., & Reeves, H. L. (2013) · doi:10.1002/9781118556153.ch17 · Cited by 1
Squires, M. H., & Kooby, D. A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1423-4_15 · Cited by 1
Choi, K. S., Kim, D., Jung, S.-W., Yu, Y., & Suh, S. O. (2014) · Korean Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.14701/kjhbps.2014.18.4.105
Is It Necessary for NAFLD Patients to be Screened for Hepatocellular Carcinoma?
Cheong, J. Y. (2014) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2014.63.5.265
Statins for chemoprevention of hepatocellular carcinoma: assessing the
Siegel, A. B., & El‐Serag, H. B. (2013)
Self-citationBarbare, J., Trinchet, J., & Verdier, H. J. (2012)
Ohba, K., Kumai, T., Iwai, S., Watanabe, M., Koizumi, G., Arai, M., Furuya, K., Oda, G., Matsumoto, N., Kobayashi, S., et al. (2012)
Metabolic syndrome and hepatocellular carcinoma: an advance in epidemiology study
Zhao, J., & Gao, C. (2010) · Academic Journal of Second Military Medical University · doi:10.3724/sp.j.1008.2010.00425
Diagnosis of Hepatobiliary Malignancies
Xu, S., Guo, X., Shaffer, V. O., Hao, J., & Cai, Q. (2015) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814618991_0017
Hepatocellular Carcinoma in Nonalcoholic Steatohepatitis
Koppe, S., & Arshad, H. M. S. (2017) · Digestive Disease Interventions · doi:10.1055/s-0037-1603572
Carcinome hépatocellulaire : nous sommes à l’aube d’une nouvelle époque !
Raoul, J. (2017) · ONCOLOGIE · doi:10.1007/s10269-017-2715-z
Syndrome métabolique et chirurgie hépatique
Hobeika, C., Ronot, M., Bèaufrere, A., Paradis, V., Soubrane, O., & Cauchy, F. (2019) · Journal de Chirurgie Viscérale · doi:10.1016/j.jchirv.2019.08.004
Susanto, H., Ardana, I. K. K. G., Pertiwi, M. P., Khasna, E. N., Ghofur, A., Handaya, A. Y., & Ariani, N. L. (2020) · AIP conference proceedings · doi:10.1063/5.0002471
Hepatic steatosis, steatohepatitis, and chemotherapy-related liver injury
Reddy, S. K., & Geller, D. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-34062-5.00071-6
Searching for biomarkers of non-alcoholic fatty liver disease and metabolic syndrome
delaCruz‐Villar, L. (2020) · Communities in ADDI (University of the Basque Country)
Gut Microbiome and Liver Cancer
McVey, J. C., Zhang, Q., Greten, T. F., & Ma, C. (2021) · Physiology in health and disease · doi:10.1007/978-3-030-67951-4_7
Şamdancı, E. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.99842
Ang, C., Reichert, S. E., & Holcombe, R. F. (2018) · doi:10.1002/9781118592168.ch7
Functional Foods for Treatment and Prevention of Obesity and Its Associated Disorders
Tingirikari, J. M. R. (2021) · IGI Global eBooks · doi:10.4018/978-1-6684-3546-5.ch053
康輔, 松., 宮内, 拓., 穣, 木., & 海堀昌樹 (2018) · The Japanese Journal of SURGICAL METABOLISM and NUTRITION · doi:10.11638/jssmn.52.6_301
Raoul, J.-L., Latournerie, M., Guillygomarc’h, A., Boudjéma, K., Audrain, O., & Boucher, É. (2011) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(11)54657-5
Shaw, R. P. H., Kolyvas, P. G., Dang, N., Hyon, A., & Anakk, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.07.459308
Epigenetic modifications and regulations in gastrointestinal diseases
Bhattacharya, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823931-5.00005-0
Chatterjee, A., Mondal, B., Das, K., Mondal, D., Ghosh, R., Chowdhury, A., & Basu, P. (2023) · medRxiv · doi:10.1101/2023.05.11.23289665
3D structural analysis of aptamer and diagnostic platforms for detecting hepatocellular carcinoma
Shin, W., Park, D. Y., Um, H., Ahn, G., Kim, S. Y., Ahn, J., & Kim, Y. (2023) · Molecular & Cellular Toxicology · doi:10.1007/s13273-023-00369-8
Targeted Analysis of Glycerophospholipids and Mono-, Di-, or Tri-Acylglycerides in Liver Cancer
Chen, H., Durand, S., Bourgin, M., Lambertucci, F., Motiño, O., Montégut, L., Li, S., Nogueira-Recalde, U., Anagnostopoulos, G., Maiuri, M. C., et al. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3694-7_14
Viana, L., Oliveira, R. C., Martins, R. J. T., Alexandrino, H., Cipriano, M. A., & Tralhão, J. G. (2024) · Gastrointestinal Disorders · doi:10.3390/gidisord6020027
Villalba, S. N. S., Paguay, L. E. C., Jácome, M. Á. E., & Arizala, J. F. C. (2024) · SCT Proceedings in Interdisciplinary Insights and Innovations. · doi:10.56294/piii2024341
Roden, M. (2024) · Springer eBooks · doi:10.1007/978-3-662-58895-6_20
A Review of the effects of Monosodium Glutamate on Gut health
Anuradha, N., Saravana Kumar, S., Hima Bindu, B. S. S. N., Gnanavel, A., & Karthick, S. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00636
Chemicals With Carcinogenic Activity Primarily in Rodent Liver
Kobets, T., & Williams, G. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00271-0
Chen, K., Feng, Q., & Liu, H. (2025) · Discover Oncology · doi:10.1007/s12672-025-02518-y
Racial and Ethnic Disparities in Outcomes in Liver Transplantation for Hepatocellular Carcinoma
Dixit, D., Warren, C. R., Duarte, S., Neal, D. W., Cabrera, R., Zori, A. G., & Zarrinpar, A. (2025) · Journal of Surgical Research · doi:10.1016/j.jss.2025.11.016
Gong, W., Lin, H., Ma, X., Ma, H., Lan, Y., Sun, P., & Yang, J. (2024) · Figshare · doi:10.6084/m9.figshare.25678534
Xia, B., Peng, J., Enrico, D. T., Lu, K., Cheung, E. C., Kuo, Z., He, Q., Tang, Y., Liu, A., Fan, D., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16767556
Gong, W., Lin, H., Ma, X., Ma, H., Lan, Y., Sun, P., & Yang, J. (2024) · Figshare · doi:10.6084/m9.figshare.25678713
Ozono, Y., Kawakami, H., Hatada, H., Uchiyama, N., Ogawa, S., Uchida, K., Tamura, H., Komaki, Y., Nakamura, K., Iwakiri, H., et al. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-04610-1
Implication du suppresseur de tumeur TP53INP1 dans l'autophagie et le métabolisme lipidique
Seillier, M. (2013) · theses.fr (ABES) · doi:10.70675/db061acdz0fddz4d26z87c9zdc0750155617
Guillou, D. L. (2017) · theses.fr (ABES) · doi:10.70675/b26d5802z0fccz434bz8f49zaa1f25db2fa1
Marqueurs diagnostiques et pronostiques de la stéatohépatite métabolique
Coilly, A. (2019) · theses.fr (ABES) · doi:10.70675/488abf31z3acfz4f13z88e2zd974ef8b9b7b
Rôle de LECT2 dans les maladies stéatosiques non alcooliques du foie
Pham, S. (2020) · theses.fr (ABES) · doi:10.70675/3693bfe6z9d91z4045za9a9zc37497dc9c1b
Guillard, J. (2023) · theses.fr (ABES) · doi:10.70675/f98c5197z2bf3z42a9z946az3cce0b05462c
Ohgi, K., Ohshima, K., Sakamoto, M., Kanai, Y., Nagashima, T., Ashida, R., Otsuka, S., Dei, H., Matsui, S., Hatakeyama, K., et al. (2026) · Hepatology Research · doi:10.1111/hepr.70260
Targeting ferroptosis to overcome drug resistance in gastrointestinal cancers
Cao, C., Qi, H., Qian, W., Xing, Y., Ma, X., Wang, Y., Chu, Y., & Jia, Y. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04550-y
De la stéatohépatite non alcoolique au carcinome hépatocellulaire : mécanismes physiopathologiques
Desbois‐Mouthon, C. (2011) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(11)70184-5
Glycaemia does not predict liver biochemistry in fatty liver disease
Shelton, E., Khaw, D., Colman, P. G., Fourlanos, S., Marion, K., & Nicoll, A. (2012) · RMIT Research Repository (RMIT University Library)
Metadata
- Authors
- Siegel, A. B., & Zhu, A. X.
- Affiliations
- Columbia University (US)
- Harvard University (US)
- Corresponding author
- Siegel, Abby B.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2009-10-15
- Volume
- 115
- Issue
- 24
- Pages
- 5651-5661
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- PMC
- PMC3397779
- OpenAlex
- W1995501999
- Cited by
- 399
- References
- 118
- Citations by year
- 2026: 3 · 2025: 15 · 2024: 19 · 2023: 12 · 2022: 19 · 2021: 22 · 2020: 19 · 2019: 19 · 2018: 22 · 2017: 25 · 2016: 15 · 2015: 27 · 2014: 29 · 2013: 45 · 2012: 34
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Center for Research Resources (K12 RR024157-03, KL2RR024157)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- metabolic syndrome, hepatocellular carcinoma, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, insulin resistance, obesity, hypertension, hyperlipidemia, cancer risk factors, oncological outcomes, pathophysiological mechanisms, HCC screening, HCC treatment
- MeSH terms
- Fatty Liver, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Obesity, Risk Factors, United States, Incidence, Survival Rate, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
